Trial Profile
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Jul 2023
Price :
$35
*
At a glance
- Drugs Vardenafil (Primary)
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Bayer; GSK
- 12 Dec 2007 Status change from in progress to completed.
- 10 Dec 2007 Results were reported at the Sexual Medicine Society of North America (SMSNA) Fall Meeting in 2007.
- 27 Jan 2007 Status change